<code id='B09B7BD2B2'></code><style id='B09B7BD2B2'></style>
    • <acronym id='B09B7BD2B2'></acronym>
      <center id='B09B7BD2B2'><center id='B09B7BD2B2'><tfoot id='B09B7BD2B2'></tfoot></center><abbr id='B09B7BD2B2'><dir id='B09B7BD2B2'><tfoot id='B09B7BD2B2'></tfoot><noframes id='B09B7BD2B2'>

    • <optgroup id='B09B7BD2B2'><strike id='B09B7BD2B2'><sup id='B09B7BD2B2'></sup></strike><code id='B09B7BD2B2'></code></optgroup>
        1. <b id='B09B7BD2B2'><label id='B09B7BD2B2'><select id='B09B7BD2B2'><dt id='B09B7BD2B2'><span id='B09B7BD2B2'></span></dt></select></label></b><u id='B09B7BD2B2'></u>
          <i id='B09B7BD2B2'><strike id='B09B7BD2B2'><tt id='B09B7BD2B2'><pre id='B09B7BD2B2'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:386
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Readout Newsletter: Biogen, Ionis, Johnson & Johnson news
          Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

          AdobeTheneed-to-knowthismorningBiogen and IonisPharmaceuticals are endingtheirdevelopment ofanexperi

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          It's time to retire 'poor historian' from clinicians' vocabularies

          AdobeShouldwepitythe“poorhistorians”—theindividualsorfamilymemberswhocan’tgiveaclearaccountingofthei